Interleukin-1-mediated immune suppression and resistance to immunotherapy in cancer

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Inflammation is associated with cancer initiation, progression, angiogenesis, and metastasis. The major proinflammatory cytokine interleukin-1 (IL-1) is involved in all aspects of carcinogenesis. Indeed, recent studies have showed a crucial role of IL-1 in the suppression of the antitumor immune response, resulting in tumor resistance to immunotherapy. In this chapter, we discuss the mechanisms of IL-1 production in the tumor microenvironment, IL-1-mediated immune suppression in various tumors, and IL-1-mediated resistance to immunotherapy.

Original languageEnglish (US)
Title of host publicationMultifaceted Role of IL-1 in Cancer and Inflammation
PublisherElsevier
Pages87-98
Number of pages12
ISBN (Electronic)9780128242735
ISBN (Print)9780323859677
DOIs
StatePublished - Jan 1 2023

Keywords

  • DAMPs
  • Immune checkpoint blockade
  • Interleukin-1
  • PAMPs
  • Proinflammatory cytokine

ASJC Scopus subject areas

  • General Agricultural and Biological Sciences
  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Interleukin-1-mediated immune suppression and resistance to immunotherapy in cancer'. Together they form a unique fingerprint.

Cite this